Brussels, 11 Oct 2005
The Council took note of the information given by Commission Vice president Günther Verheugen on the main findings of the third progress report on Life Sciences and biotechnology adopted on 29 June 2005. In this report, the Commission also sets out the priorities for future actions which will consist firstly, in carrying out an independent study aimed at providing a comprehensive assessment and cost-benefit analysis of the consequences, opportunities and challenges that applications of modern biotechnology present for Europe in terms of economic, social and environmental aspects. Secondly, the Commission will draw on both the study and an in-depth assessment of the progress achieved since 2002 to update the Community Strategy on Life Sciences and Biotechnology in good time for the 2007 Spring European Council.
1 In January 2002, the Commission adopted a Strategy for Europe on Life Sciences and Biotechnology, consisting of two parts – policy orientations and a 30-point plan to transform policy into action. It sets out what is needed from the Commission and the other European Institutions, while also recommending actions for other public and private stakeholders. The Commission reports regularly on the progress made.